ReviewDrug design, development and therapy2016

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy.

Jennifer Hayes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.